BillionToOne, Inc.
BLLN
Classifica tra le azioni
#3471
BillionToOne, Inc. is a specialized diagnostics company that innovates by... BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Prezzo delle azioni
$105.11
Ultima sincronizzazione: 2026-10-21
Capitalizzazione di mercato
$4.96B
Variazione (1 giorno)
1.56%
Variazione (1 anno)
-
Paese
US
Scambia BillionToOne, Inc. (BLLN)
Categoria
Healthcare
Storico del prezzo dell'azione per BillionToOne, Inc. (BLLN)
Prezzo di chiusura più alto: $100.39 il 2026-10-01
Prezzo di chiusura più basso: $106.24 il 2025-11-01
Prezzo di chiusura più basso: $106.24 il 2025-11-01
Storico del prezzo dell'azione di BillionToOne, Inc. dal 2025 al 2026
Andamento annuale del prezzo dell'azione
| Anno | Performance |
|---|---|
| 2026 (TTM) | -1.87% |
| 2025 | 0.00% |
Prezzo dell'azione per aziende simili o concorrenti
| Azienda | Prezzo dell'azione | Variazione 1a% | Il paese |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.75 | 53.60% |
CN
|
|
| $177.93 | 21.98% |
US
|
